Serveur d'exploration sur le peuplier

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Allostatic load is associated with psychotic symptoms and decreases with antipsychotic treatment in patients with schizophrenia and first-episode psychosis.

Identifieur interne : 001060 ( Main/Exploration ); précédent : 001059; suivant : 001061

Allostatic load is associated with psychotic symptoms and decreases with antipsychotic treatment in patients with schizophrenia and first-episode psychosis.

Auteurs : Maximus Berger [Australie] ; Robert-Paul Juster [États-Unis] ; Sabine Westphal [Allemagne] ; G Paul Amminger [Australie] ; Bernhard Bogerts [Allemagne] ; Kolja Schiltz [Allemagne] ; Sabine Bahn [Royaume-Uni] ; Johann Steiner [Allemagne] ; Zoltan Sarnyai [Australie]

Source :

RBID : pubmed:29427955

Descripteurs français

English descriptors

Abstract

Current pathophysiological models of schizophrenia suggest that stress contributes to the etiology and trajectory of the disorder. We investigated if allostatic load (AL), an integrative index of neuroendocrine, immune and metabolic dysregulation in response to chronic stress, is elevated in patients with schizophrenia (SCZ) and first-episode psychosis (FEP) and related to psychotic symptoms and social and occupational functioning. Additionally, we assessed the temporal dynamics of AL in response to treatment with second-generation antipsychotics. AL, psychotic symptoms and psychosocial functioning were assessed in a longitudinal design in patients with SCZ (n = 28), FEP (n = 28), and healthy controls (n = 53) at baseline and 6 and 12 weeks after commencement of antipsychotic therapy. AL at baseline was higher in patients with SCZ and FEP relative to controls, but not different between patients with SCZ and FEP. Adjusting for age and smoking, we found that positive symptoms were positively correlated with AL and psychosocial functioning was negatively correlated with AL at trend level. Linear mixed model analysis demonstrated that AL decreased after treatment was commenced in patients with SCZ and FEP between the baseline assessment and the 6 and 12-week follow-up. AL was not predictive of treatment response or symptomatic remission. Our data provide evidence for cumulative physiological dysregulation in patients with SCZ and FEP that is linked to the experience of current positive psychotic symptoms. AL could be a useful tool to monitor biological signatures related to chronic stress and unhealthy behaviors in schizophrenia.

DOI: 10.1016/j.psyneuen.2018.02.001
PubMed: 29427955


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Allostatic load is associated with psychotic symptoms and decreases with antipsychotic treatment in patients with schizophrenia and first-episode psychosis.</title>
<author>
<name sortKey="Berger, Maximus" sort="Berger, Maximus" uniqKey="Berger M" first="Maximus" last="Berger">Maximus Berger</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Psychiatric Neuroscience, Australian Institute of Tropical Health and Medicine (AITHM), 1 James Cook Drive, Townsville, QLD, 4811, Australia, Australia; College of Public Health, Medical and Veterinary Science, James Cook University, 1 James Cook Drive, Townsville, QLD, 4811, Australia; Orygen, The National Centre of Excellence in Youth Mental Health, 35 Poplar Rd, Parkville, VIC, 3052, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Laboratory of Psychiatric Neuroscience, Australian Institute of Tropical Health and Medicine (AITHM), 1 James Cook Drive, Townsville, QLD, 4811, Australia, Australia; College of Public Health, Medical and Veterinary Science, James Cook University, 1 James Cook Drive, Townsville, QLD, 4811, Australia; Orygen, The National Centre of Excellence in Youth Mental Health, 35 Poplar Rd, Parkville, VIC, 3052</wicri:regionArea>
<wicri:noRegion>3052</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Juster, Robert Paul" sort="Juster, Robert Paul" uniqKey="Juster R" first="Robert-Paul" last="Juster">Robert-Paul Juster</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Psychiatry, Columbia University Medical Center, Columbia University, 3960 Broadway, New York, NY, 10032, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Psychiatry, Columbia University Medical Center, Columbia University, 3960 Broadway, New York, NY, 10032</wicri:regionArea>
<wicri:noRegion>10032</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Westphal, Sabine" sort="Westphal, Sabine" uniqKey="Westphal S" first="Sabine" last="Westphal">Sabine Westphal</name>
<affiliation wicri:level="3">
<nlm:affiliation>Institute of Clinical Chemistry and Pathobiochemistry, University of Magdeburg, Leipziger Str. 44, Magdeburg, D-39120, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Clinical Chemistry and Pathobiochemistry, University of Magdeburg, Leipziger Str. 44, Magdeburg, D-39120</wicri:regionArea>
<placeName>
<region type="land" nuts="2">Saxe-Anhalt</region>
<settlement type="city">Magdebourg</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Amminger, G Paul" sort="Amminger, G Paul" uniqKey="Amminger G" first="G Paul" last="Amminger">G Paul Amminger</name>
<affiliation wicri:level="1">
<nlm:affiliation>Orygen, The National Centre of Excellence in Youth Mental Health, 35 Poplar Rd, Parkville, VIC, 3052, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Orygen, The National Centre of Excellence in Youth Mental Health, 35 Poplar Rd, Parkville, VIC, 3052</wicri:regionArea>
<wicri:noRegion>3052</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Bogerts, Bernhard" sort="Bogerts, Bernhard" uniqKey="Bogerts B" first="Bernhard" last="Bogerts">Bernhard Bogerts</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Psychiatry, University of Magdeburg, Leipziger Str. 44, Magdeburg, D-39120, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Psychiatry, University of Magdeburg, Leipziger Str. 44, Magdeburg, D-39120</wicri:regionArea>
<placeName>
<region type="land" nuts="2">Saxe-Anhalt</region>
<settlement type="city">Magdebourg</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Schiltz, Kolja" sort="Schiltz, Kolja" uniqKey="Schiltz K" first="Kolja" last="Schiltz">Kolja Schiltz</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Forensic Psychiatry, Psychiatric Hospital of the Ludwig-Maximilians-University München, Nußbaumstr. 7, D-80336, München, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Forensic Psychiatry, Psychiatric Hospital of the Ludwig-Maximilians-University München, Nußbaumstr. 7, D-80336, München</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bahn, Sabine" sort="Bahn, Sabine" uniqKey="Bahn S" first="Sabine" last="Bahn">Sabine Bahn</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge</wicri:regionArea>
<orgName type="university">Université de Cambridge</orgName>
<placeName>
<settlement type="city">Cambridge</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Angleterre de l'Est</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Steiner, Johann" sort="Steiner, Johann" uniqKey="Steiner J" first="Johann" last="Steiner">Johann Steiner</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Psychiatry, University of Magdeburg, Leipziger Str. 44, Magdeburg, D-39120, Germany. Electronic address: johann.steiner@med.ovgu.de.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Psychiatry, University of Magdeburg, Leipziger Str. 44, Magdeburg, D-39120</wicri:regionArea>
<placeName>
<region type="land" nuts="2">Saxe-Anhalt</region>
<settlement type="city">Magdebourg</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Sarnyai, Zoltan" sort="Sarnyai, Zoltan" uniqKey="Sarnyai Z" first="Zoltan" last="Sarnyai">Zoltan Sarnyai</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Psychiatric Neuroscience, Australian Institute of Tropical Health and Medicine (AITHM), 1 James Cook Drive, Townsville, QLD, 4811, Australia, Australia; College of Public Health, Medical and Veterinary Science, James Cook University, 1 James Cook Drive, Townsville, QLD, 4811, Australia. Electronic address: zoltan.sarnyai@jcu.edu.au.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Laboratory of Psychiatric Neuroscience, Australian Institute of Tropical Health and Medicine (AITHM), 1 James Cook Drive, Townsville, QLD, 4811, Australia, Australia; College of Public Health, Medical and Veterinary Science, James Cook University, 1 James Cook Drive, Townsville, QLD, 4811</wicri:regionArea>
<wicri:noRegion>4811</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:29427955</idno>
<idno type="pmid">29427955</idno>
<idno type="doi">10.1016/j.psyneuen.2018.02.001</idno>
<idno type="wicri:Area/Main/Corpus">000F71</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000F71</idno>
<idno type="wicri:Area/Main/Curation">000F71</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000F71</idno>
<idno type="wicri:Area/Main/Exploration">000F71</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Allostatic load is associated with psychotic symptoms and decreases with antipsychotic treatment in patients with schizophrenia and first-episode psychosis.</title>
<author>
<name sortKey="Berger, Maximus" sort="Berger, Maximus" uniqKey="Berger M" first="Maximus" last="Berger">Maximus Berger</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Psychiatric Neuroscience, Australian Institute of Tropical Health and Medicine (AITHM), 1 James Cook Drive, Townsville, QLD, 4811, Australia, Australia; College of Public Health, Medical and Veterinary Science, James Cook University, 1 James Cook Drive, Townsville, QLD, 4811, Australia; Orygen, The National Centre of Excellence in Youth Mental Health, 35 Poplar Rd, Parkville, VIC, 3052, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Laboratory of Psychiatric Neuroscience, Australian Institute of Tropical Health and Medicine (AITHM), 1 James Cook Drive, Townsville, QLD, 4811, Australia, Australia; College of Public Health, Medical and Veterinary Science, James Cook University, 1 James Cook Drive, Townsville, QLD, 4811, Australia; Orygen, The National Centre of Excellence in Youth Mental Health, 35 Poplar Rd, Parkville, VIC, 3052</wicri:regionArea>
<wicri:noRegion>3052</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Juster, Robert Paul" sort="Juster, Robert Paul" uniqKey="Juster R" first="Robert-Paul" last="Juster">Robert-Paul Juster</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Psychiatry, Columbia University Medical Center, Columbia University, 3960 Broadway, New York, NY, 10032, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Psychiatry, Columbia University Medical Center, Columbia University, 3960 Broadway, New York, NY, 10032</wicri:regionArea>
<wicri:noRegion>10032</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Westphal, Sabine" sort="Westphal, Sabine" uniqKey="Westphal S" first="Sabine" last="Westphal">Sabine Westphal</name>
<affiliation wicri:level="3">
<nlm:affiliation>Institute of Clinical Chemistry and Pathobiochemistry, University of Magdeburg, Leipziger Str. 44, Magdeburg, D-39120, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Clinical Chemistry and Pathobiochemistry, University of Magdeburg, Leipziger Str. 44, Magdeburg, D-39120</wicri:regionArea>
<placeName>
<region type="land" nuts="2">Saxe-Anhalt</region>
<settlement type="city">Magdebourg</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Amminger, G Paul" sort="Amminger, G Paul" uniqKey="Amminger G" first="G Paul" last="Amminger">G Paul Amminger</name>
<affiliation wicri:level="1">
<nlm:affiliation>Orygen, The National Centre of Excellence in Youth Mental Health, 35 Poplar Rd, Parkville, VIC, 3052, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Orygen, The National Centre of Excellence in Youth Mental Health, 35 Poplar Rd, Parkville, VIC, 3052</wicri:regionArea>
<wicri:noRegion>3052</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Bogerts, Bernhard" sort="Bogerts, Bernhard" uniqKey="Bogerts B" first="Bernhard" last="Bogerts">Bernhard Bogerts</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Psychiatry, University of Magdeburg, Leipziger Str. 44, Magdeburg, D-39120, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Psychiatry, University of Magdeburg, Leipziger Str. 44, Magdeburg, D-39120</wicri:regionArea>
<placeName>
<region type="land" nuts="2">Saxe-Anhalt</region>
<settlement type="city">Magdebourg</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Schiltz, Kolja" sort="Schiltz, Kolja" uniqKey="Schiltz K" first="Kolja" last="Schiltz">Kolja Schiltz</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Forensic Psychiatry, Psychiatric Hospital of the Ludwig-Maximilians-University München, Nußbaumstr. 7, D-80336, München, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Forensic Psychiatry, Psychiatric Hospital of the Ludwig-Maximilians-University München, Nußbaumstr. 7, D-80336, München</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bahn, Sabine" sort="Bahn, Sabine" uniqKey="Bahn S" first="Sabine" last="Bahn">Sabine Bahn</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge</wicri:regionArea>
<orgName type="university">Université de Cambridge</orgName>
<placeName>
<settlement type="city">Cambridge</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Angleterre de l'Est</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Steiner, Johann" sort="Steiner, Johann" uniqKey="Steiner J" first="Johann" last="Steiner">Johann Steiner</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Psychiatry, University of Magdeburg, Leipziger Str. 44, Magdeburg, D-39120, Germany. Electronic address: johann.steiner@med.ovgu.de.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Psychiatry, University of Magdeburg, Leipziger Str. 44, Magdeburg, D-39120</wicri:regionArea>
<placeName>
<region type="land" nuts="2">Saxe-Anhalt</region>
<settlement type="city">Magdebourg</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Sarnyai, Zoltan" sort="Sarnyai, Zoltan" uniqKey="Sarnyai Z" first="Zoltan" last="Sarnyai">Zoltan Sarnyai</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Psychiatric Neuroscience, Australian Institute of Tropical Health and Medicine (AITHM), 1 James Cook Drive, Townsville, QLD, 4811, Australia, Australia; College of Public Health, Medical and Veterinary Science, James Cook University, 1 James Cook Drive, Townsville, QLD, 4811, Australia. Electronic address: zoltan.sarnyai@jcu.edu.au.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Laboratory of Psychiatric Neuroscience, Australian Institute of Tropical Health and Medicine (AITHM), 1 James Cook Drive, Townsville, QLD, 4811, Australia, Australia; College of Public Health, Medical and Veterinary Science, James Cook University, 1 James Cook Drive, Townsville, QLD, 4811</wicri:regionArea>
<wicri:noRegion>4811</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Psychoneuroendocrinology</title>
<idno type="eISSN">1873-3360</idno>
<imprint>
<date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult (MeSH)</term>
<term>Allostasis (drug effects)</term>
<term>Allostasis (physiology)</term>
<term>Antipsychotic Agents (administration & dosage)</term>
<term>Biomarkers (metabolism)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Male (MeSH)</term>
<term>Psychiatric Status Rating Scales (MeSH)</term>
<term>Psychotic Disorders (drug therapy)</term>
<term>Psychotic Disorders (metabolism)</term>
<term>Schizophrenia (drug therapy)</term>
<term>Schizophrenia (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte (MeSH)</term>
<term>Allostasie (effets des médicaments et des substances chimiques)</term>
<term>Allostasie (physiologie)</term>
<term>Femelle (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Marqueurs biologiques (métabolisme)</term>
<term>Mâle (MeSH)</term>
<term>Neuroleptiques (administration et posologie)</term>
<term>Schizophrénie (métabolisme)</term>
<term>Schizophrénie (traitement médicamenteux)</term>
<term>Troubles psychotiques (métabolisme)</term>
<term>Troubles psychotiques (traitement médicamenteux)</term>
<term>Échelles d'évaluation en psychiatrie (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Antipsychotic Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>Neuroleptiques</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Allostasis</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Psychotic Disorders</term>
<term>Schizophrenia</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr">
<term>Allostasie</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Biomarkers</term>
<term>Psychotic Disorders</term>
<term>Schizophrenia</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Marqueurs biologiques</term>
<term>Schizophrénie</term>
<term>Troubles psychotiques</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Allostasie</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Allostasis</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Schizophrénie</term>
<term>Troubles psychotiques</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Psychiatric Status Rating Scales</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Échelles d'évaluation en psychiatrie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Current pathophysiological models of schizophrenia suggest that stress contributes to the etiology and trajectory of the disorder. We investigated if allostatic load (AL), an integrative index of neuroendocrine, immune and metabolic dysregulation in response to chronic stress, is elevated in patients with schizophrenia (SCZ) and first-episode psychosis (FEP) and related to psychotic symptoms and social and occupational functioning. Additionally, we assessed the temporal dynamics of AL in response to treatment with second-generation antipsychotics. AL, psychotic symptoms and psychosocial functioning were assessed in a longitudinal design in patients with SCZ (n = 28), FEP (n = 28), and healthy controls (n = 53) at baseline and 6 and 12 weeks after commencement of antipsychotic therapy. AL at baseline was higher in patients with SCZ and FEP relative to controls, but not different between patients with SCZ and FEP. Adjusting for age and smoking, we found that positive symptoms were positively correlated with AL and psychosocial functioning was negatively correlated with AL at trend level. Linear mixed model analysis demonstrated that AL decreased after treatment was commenced in patients with SCZ and FEP between the baseline assessment and the 6 and 12-week follow-up. AL was not predictive of treatment response or symptomatic remission. Our data provide evidence for cumulative physiological dysregulation in patients with SCZ and FEP that is linked to the experience of current positive psychotic symptoms. AL could be a useful tool to monitor biological signatures related to chronic stress and unhealthy behaviors in schizophrenia.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">29427955</PMID>
<DateCompleted>
<Year>2019</Year>
<Month>01</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>01</Month>
<Day>22</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-3360</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>90</Volume>
<PubDate>
<Year>2018</Year>
<Month>04</Month>
</PubDate>
</JournalIssue>
<Title>Psychoneuroendocrinology</Title>
<ISOAbbreviation>Psychoneuroendocrinology</ISOAbbreviation>
</Journal>
<ArticleTitle>Allostatic load is associated with psychotic symptoms and decreases with antipsychotic treatment in patients with schizophrenia and first-episode psychosis.</ArticleTitle>
<Pagination>
<MedlinePgn>35-42</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0306-4530(17)31550-0</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.psyneuen.2018.02.001</ELocationID>
<Abstract>
<AbstractText>Current pathophysiological models of schizophrenia suggest that stress contributes to the etiology and trajectory of the disorder. We investigated if allostatic load (AL), an integrative index of neuroendocrine, immune and metabolic dysregulation in response to chronic stress, is elevated in patients with schizophrenia (SCZ) and first-episode psychosis (FEP) and related to psychotic symptoms and social and occupational functioning. Additionally, we assessed the temporal dynamics of AL in response to treatment with second-generation antipsychotics. AL, psychotic symptoms and psychosocial functioning were assessed in a longitudinal design in patients with SCZ (n = 28), FEP (n = 28), and healthy controls (n = 53) at baseline and 6 and 12 weeks after commencement of antipsychotic therapy. AL at baseline was higher in patients with SCZ and FEP relative to controls, but not different between patients with SCZ and FEP. Adjusting for age and smoking, we found that positive symptoms were positively correlated with AL and psychosocial functioning was negatively correlated with AL at trend level. Linear mixed model analysis demonstrated that AL decreased after treatment was commenced in patients with SCZ and FEP between the baseline assessment and the 6 and 12-week follow-up. AL was not predictive of treatment response or symptomatic remission. Our data provide evidence for cumulative physiological dysregulation in patients with SCZ and FEP that is linked to the experience of current positive psychotic symptoms. AL could be a useful tool to monitor biological signatures related to chronic stress and unhealthy behaviors in schizophrenia.</AbstractText>
<CopyrightInformation>Copyright © 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Berger</LastName>
<ForeName>Maximus</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Psychiatric Neuroscience, Australian Institute of Tropical Health and Medicine (AITHM), 1 James Cook Drive, Townsville, QLD, 4811, Australia, Australia; College of Public Health, Medical and Veterinary Science, James Cook University, 1 James Cook Drive, Townsville, QLD, 4811, Australia; Orygen, The National Centre of Excellence in Youth Mental Health, 35 Poplar Rd, Parkville, VIC, 3052, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Juster</LastName>
<ForeName>Robert-Paul</ForeName>
<Initials>RP</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Columbia University Medical Center, Columbia University, 3960 Broadway, New York, NY, 10032, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Westphal</LastName>
<ForeName>Sabine</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Institute of Clinical Chemistry and Pathobiochemistry, University of Magdeburg, Leipziger Str. 44, Magdeburg, D-39120, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Amminger</LastName>
<ForeName>G Paul</ForeName>
<Initials>GP</Initials>
<AffiliationInfo>
<Affiliation>Orygen, The National Centre of Excellence in Youth Mental Health, 35 Poplar Rd, Parkville, VIC, 3052, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bogerts</LastName>
<ForeName>Bernhard</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, University of Magdeburg, Leipziger Str. 44, Magdeburg, D-39120, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schiltz</LastName>
<ForeName>Kolja</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Forensic Psychiatry, Psychiatric Hospital of the Ludwig-Maximilians-University München, Nußbaumstr. 7, D-80336, München, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bahn</LastName>
<ForeName>Sabine</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Steiner</LastName>
<ForeName>Johann</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, University of Magdeburg, Leipziger Str. 44, Magdeburg, D-39120, Germany. Electronic address: johann.steiner@med.ovgu.de.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sarnyai</LastName>
<ForeName>Zoltan</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Psychiatric Neuroscience, Australian Institute of Tropical Health and Medicine (AITHM), 1 James Cook Drive, Townsville, QLD, 4811, Australia, Australia; College of Public Health, Medical and Veterinary Science, James Cook University, 1 James Cook Drive, Townsville, QLD, 4811, Australia. Electronic address: zoltan.sarnyai@jcu.edu.au.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2018</Year>
<Month>02</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Psychoneuroendocrinology</MedlineTA>
<NlmUniqueID>7612148</NlmUniqueID>
<ISSNLinking>0306-4530</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D052636" MajorTopicYN="N">Allostasis</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014150" MajorTopicYN="N">Antipsychotic Agents</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011618" MajorTopicYN="N">Psychotic Disorders</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012559" MajorTopicYN="N">Schizophrenia</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">Allostatic load</Keyword>
<Keyword MajorTopicYN="Y">Biomarkers</Keyword>
<Keyword MajorTopicYN="Y">First-episode psychosis</Keyword>
<Keyword MajorTopicYN="Y">Hpa-axis</Keyword>
<Keyword MajorTopicYN="Y">Schizophrenia</Keyword>
<Keyword MajorTopicYN="Y">Treatment outcomes</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2017</Year>
<Month>11</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2018</Year>
<Month>01</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2018</Year>
<Month>02</Month>
<Day>01</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2018</Year>
<Month>2</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2019</Year>
<Month>1</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2018</Year>
<Month>2</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">29427955</ArticleId>
<ArticleId IdType="pii">S0306-4530(17)31550-0</ArticleId>
<ArticleId IdType="doi">10.1016/j.psyneuen.2018.02.001</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Allemagne</li>
<li>Australie</li>
<li>Royaume-Uni</li>
<li>États-Unis</li>
</country>
<region>
<li>Angleterre</li>
<li>Angleterre de l'Est</li>
<li>Bavière</li>
<li>District de Haute-Bavière</li>
<li>Saxe-Anhalt</li>
</region>
<settlement>
<li>Cambridge</li>
<li>Magdebourg</li>
<li>Munich</li>
</settlement>
<orgName>
<li>Université de Cambridge</li>
</orgName>
</list>
<tree>
<country name="Australie">
<noRegion>
<name sortKey="Berger, Maximus" sort="Berger, Maximus" uniqKey="Berger M" first="Maximus" last="Berger">Maximus Berger</name>
</noRegion>
<name sortKey="Amminger, G Paul" sort="Amminger, G Paul" uniqKey="Amminger G" first="G Paul" last="Amminger">G Paul Amminger</name>
<name sortKey="Sarnyai, Zoltan" sort="Sarnyai, Zoltan" uniqKey="Sarnyai Z" first="Zoltan" last="Sarnyai">Zoltan Sarnyai</name>
</country>
<country name="États-Unis">
<noRegion>
<name sortKey="Juster, Robert Paul" sort="Juster, Robert Paul" uniqKey="Juster R" first="Robert-Paul" last="Juster">Robert-Paul Juster</name>
</noRegion>
</country>
<country name="Allemagne">
<region name="Saxe-Anhalt">
<name sortKey="Westphal, Sabine" sort="Westphal, Sabine" uniqKey="Westphal S" first="Sabine" last="Westphal">Sabine Westphal</name>
</region>
<name sortKey="Bogerts, Bernhard" sort="Bogerts, Bernhard" uniqKey="Bogerts B" first="Bernhard" last="Bogerts">Bernhard Bogerts</name>
<name sortKey="Schiltz, Kolja" sort="Schiltz, Kolja" uniqKey="Schiltz K" first="Kolja" last="Schiltz">Kolja Schiltz</name>
<name sortKey="Steiner, Johann" sort="Steiner, Johann" uniqKey="Steiner J" first="Johann" last="Steiner">Johann Steiner</name>
</country>
<country name="Royaume-Uni">
<region name="Angleterre">
<name sortKey="Bahn, Sabine" sort="Bahn, Sabine" uniqKey="Bahn S" first="Sabine" last="Bahn">Sabine Bahn</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/PoplarV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001060 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001060 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    PoplarV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:29427955
   |texte=   Allostatic load is associated with psychotic symptoms and decreases with antipsychotic treatment in patients with schizophrenia and first-episode psychosis.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:29427955" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a PoplarV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Wed Nov 18 12:07:19 2020. Site generation: Wed Nov 18 12:16:31 2020